DRUG Stock-Based Compensation
Bright Minds Biosciences Inc · Stock-Based Compensation
DRUG Stock-Based Compensation
Latest reported$2.35M CADperiod ending
DRUG TTM Stock-Based Comp · CAD ($161.30K → $2.35M)
TTM stock-based compensation
High-resolution chart · PNG
DRUG stock-based compensation history
Trailing twelve months (TTM) · CAD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (CAD) |
|---|---|
| 2,354,223 | |
| 3,675,595 | |
| 4,291,503 | |
| 3,182,703 | |
| 2,323,910 | |
| 1,186,479 | |
| 797,213 | |
| 839,771 | |
| 1,030,029 | |
| 1,083,623 | |
| 886,937 | |
| 1,152,131 | |
| 781,549 | |
| 837,394 | |
| 1,098,273 | |
| 875,056 | |
| 1,221,706 | |
| 1,189,122 | |
| 1,023,528 | |
| 880,615 | |
| 665,350 | |
| 404,554 | |
| 279,313 | |
| 161,300 |